EP0446570A3
Gabapentin and its derivatives for treating neurodegenerative diseases
Abstract
The instant invention is novel uses of known cyclic amino acids. Such compounds as gabapentin are used for treating neurodegenerative disorders, perinatal asphyxia, statusepilepticus, Alzheimer's, Huntington's, Parkinson's, and Amyotrophic Lateral Sclerosis.
Term
Term ended
Projected expiry passed 2 January 2011, 15.7 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during |
|---|---|---|---|---|
| US4024175A | Cites | United States of America | AD | Search report |
11 members in 7 offices
Priority claims6
| Document | Office | Kind | Date |
|---|---|---|---|
| 459912 | United States of America | – | |
| 45991290 | United States of America | A | |
| 615151 | United States of America | – | |
| 61515190 | United States of America | A | |
| US19900459912 | – | – | – |
| US19900615151 | – | – | – |
Members11
| Document | Office | Kind | |
|---|---|---|---|
| EP0446570A2 | European Patent Office (EPO) | A2 | |
| US5084479A | United States of America | A | |
| EP0446570A3This record | European Patent Office (EPO) | A3 | |
| JPH04210915A | Japan | A | |
| EP0446570B1 | European Patent Office (EPO) | B1 | |
| AT125701T | Austria | T | |
| DE69111642D1 | Germany | D1 | |
| DK0446570T3 | Denmark | T3 | |
| DE69111642T2 | Germany | T2 | |
| HK1005166A1 | Hong Kong, China | A1 | |
| JP2903434B2 | Japan | B2 |
47 legal events, as 5 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Notification of lapseLapsedST | ST | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Ep patent lapsedLapsedEBP | EBP | DK | |
| Nl: lapsed or anulled due to non-payment of the annual feeLapsedNLV4 | NLV4 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Ep patent with danish claimsT3 | T3 | DK | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Fr: translation filedET | ET | EP | |
| Corresponds to:REF | REF | EP | |
| Designated contracting statesAK | AK | EP | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0446570
- Publication, DOCDB
- 0446570
- Publication, EPODOC
- EP0446570
- Application
- 100109
- Application, DOCDB
- 91100109
- Application, EPODOC
- EP19910100109
Titles3
- English
- Gabapentin and its derivatives for treating neurodegenerative diseases
- German
- Gabapentin und dessen Derivate zur Behandlung neurodegenerativer Krankheiten
- French
- Gabapentine et ses dérivés pour le traitement des troubles neurodégénérescents
Classification
- CPC, 5
- A61K31/195
- A61K31/22
- A61P25/00
- A61P25/28
- A61P43/00
- IPC, 7
- A61K31 195
- A61K31 215
- A61K31 22
- A61P25 00
- A61P25 28
- A61P43 00
- C07C229 28
Designated states12
- Contracting states, 12
- Austria
- Belgium
- Switzerland
- Germany
- Denmark
- France
- United Kingdom
- Italy
- Liechtenstein
- Luxembourg
- Netherlands (Kingdom of the)
- Sweden